Position in TVGN
as of Mar 31, 2026
· filed May 6, 2026
Position Value
$623
-$1,676 QoQ
Shares Held
138
-0.7% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2024
8 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in TVGN Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026NEW YORK STATE COMMON RETIREMENT FUND holds $1,001,134,385 across 287 Biotechnology names.
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
277,614 | $137,899,202 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
111,369 | $69,443,026 | |
| 3 | ASND |
Ascendis Pharma A/S
|
191,791 | $51,154,495 | |
| 4 | MDGL |
Madrigal Pharmaceuticals, Inc.
|
94,743 | $50,872,253 | |
| 5 | TWST |
Twist Bioscience Corp
|
462,145 | $47,545,477 | |
| 6 | LGND |
Ligand Pharmaceuticals Inc
|
137,258 | $43,385,881 | |
| 7 | IONS |
Ionis Pharmaceuticals Inc
|
500,050 | $39,648,964 | |
| 8 | INSM |
INSMED Inc
|
304,236 | $32,437,642 |
All Filings in TVGN
Export CSV
8 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $623 | 138 | Shares | Sole | 2026-05-06 | |
| 2025-12-31 | $2,299 | 6,946 | Shares | Sole | 2026-02-12 | |
| 2025-09-30 | $5,452 | 6,946 | Shares | Sole | 2025-11-03 | |
| 2025-06-30 | $8,682 | 6,946 | Shares | Sole | 2025-10-08 | |
| 2025-03-31 | $7,501 | 6,946 | Shares | Sole | 2025-10-08 | |
| 2024-12-31 | $7,154 | 6,946 | Shares | Sole | 2025-10-08 | |
| 2024-09-30 | $46,532 | 126,446 | Shares | Sole | 2025-10-08 | |
| 2024-06-30 | $99,051 | 137,000 | Shares | Sole | 2025-10-08 | |
| No filing history on record for this holder in this stock. | ||||||